L3112016EN2510120161117EN0004251251<p xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">Corrigendum to Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC</p>
<p xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">(Official Journal of the European Union L 158 of 27 May 2014)</p>On page 28, Article 23(5):<p xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><!--default P | TXT -->for:</p>
<mod xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
   <quotedStructure startQuote="" endQuote="">
      <p><!--default P | TXT -->&apos;Where the conclusion … is that the substantial modification is not acceptable, that conclusion shall be deemed to be the conclusion of the Member State concerned.&apos;,</p>
   </quotedStructure>
</mod>
<p xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><!--default P | TXT -->read:</p>
<mod xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
   <quotedStructure startQuote="" endQuote="">
      <p><!--default P | TXT -->&apos;Where the conclusion … is that the substantial modification is not acceptable, that conclusion shall be deemed to be the conclusion of all Member States concerned.&apos;.</p>
   </quotedStructure>
</mod>
